Aktiviere Job-Benachrichtigungen per E-Mail!
A biopharmaceutical company in Zug is seeking a Senior Technical Manager Drug Substance to lead drug substance development and control strategy. The ideal candidate has over 10 years of experience in operations within the pharma industry and excels in project management and collaboration. This role offers a hybrid working environment, balancing time between home and office.
Senior Technical Manager Drug Substance at MoonLake Immunotherapeutics (NASDAQ: MLTX). This role acts as the technical leader and subject matter expert responsible for drug substance development, control strategy, transfers, GMP manufacturing and supply from CDMOs in support of MoonLake’s global clinical development programs.
Education: Bachelor/Master of Science in Biotechnology or relevant discipline.
MoonLake is a dynamic and innovative company pushing the boundaries of possibility. We are looking for passionate individuals to join our stellar team.
Learning Environment: An opportunity to learn and grow alongside experienced professionals in a supportive and innovative biotech environment.
Impactful Work: Contribute to ground-breaking projects that have the potential to transform global healthcare.
Flexibility and Balance: Work remotely/hybrid, enjoying a healthy work-life balance while making meaningful contributions to our team.
Career Growth: A clear path for career progression with opportunities to take on more responsibilities as you develop your skills.
We look for MoonLakers who embody three core values that drive our pursuit of excellence:
We do Stellar Science: We aspire to create novel therapies with innovative science, high quality, always.
We go beyond: We aspire to be positively disruptive and bold in challenging norms.
We unlock value: We aspire to create long-term value for investors and communities.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody for the treatment of inflammatory disease. We focus on inflammatory diseases with major unmet needs, including hidradenitis suppurativa and psoriatic arthritis. MoonLake was founded in 2021 and is headquartered in Zug, with hubs in Cambridge & Porto. Further information is available at www.moonlaketx.com